A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer

Clinical trial NCT02716792 · COMPLETED

Trial details

NCT number: NCT02716792
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pain; Bone Neoplasms; Neoplasm Metastasis

Start date: 2006-01-01
Primary completion: 2008-06-01
Enrollment: 334

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.